| 生物活性 | |||
|---|---|---|---|
| 描述 | BAY 41-2272, an oral and soluble activator of guanylate cyclases (sGC), enhances sGC activity 400-fold in combination with NO. It effectively reduces cardiac workload and boosts cardiac output, making it suitable for cardiovascular disease research[1][2]. | ||
| 作用机制 | BAY 41-2272 binds to α1-subunit of sGC through Cys 238 and Cys 243.[1] | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.77mL 0.55mL 0.28mL | 13.87mL 2.77mL 1.39mL | 27.75mL 5.55mL 2.77mL | 
| 参考文献 | 
|---|